Conjunctival Melanoma: Outcomes Based on Tumor Origin in 382 Consecutive Cases
Overview
Authors
Affiliations
Purpose: To evaluate prognostic factors based on origin of conjunctival melanoma.
Design: Interventional case series.
Participants: Three hundred eighty-two consecutive patients.
Methods: Retrospective chart review.
Main Outcome Measures: Melanoma-related metastasis and death.
Results: The melanoma arose from primary acquired melanosis (PAM; n = 284; 74%), from pre-existing nevus (n = 26; 7%), and de novo (n = 72; 19%). The mean tumor base was 11 mm for melanoma arising from PAM, 6 mm for melanoma arising from nevus, and 10 mm for those arising de novo. At 5 years (10 years), melanoma metastasis occurred in 19% (25%) in melanoma arising from PAM (P = 0.003), 10% (26%) in melanoma from nevus (P = 0.193), and 35% (49%) in those de novo. Factors predictive of metastasis by multivariable analysis included tumor origin de novo (P = 0.001), palpebral location (P<0.001), nodular tumor (P = 0.005), and orbital invasion (P = 0.022). At 5 years (10 years), melanoma-related death occurred in 5% (9%) in melanoma arising from PAM (P<0.001), 0% (9%) in melanoma arising from nevus (P<0.057), and 17% (35%) in those arising de novo. Factors predictive of death by multivariable analysis included tumor origin de novo (P<0.001), fornix location (P = 0.04), and nodular tumor (P = 0.001).
Conclusions: Melanoma arising de novo carries a higher risk of melanoma-related metastasis and death compared with those cases arising from PAM or nevus.
Zheng T, Wang D, Miao Y, Dong M, Liu Q, Zhang Q Front Public Health. 2025; 13:1486988.
PMID: 40008149 PMC: 11850267. DOI: 10.3389/fpubh.2025.1486988.
Epigenetics of Conjunctival Melanoma: Current Knowledge and Future Directions.
Flick K, Demirci H, Demirci F Cancers (Basel). 2024; 16(21).
PMID: 39518125 PMC: 11544918. DOI: 10.3390/cancers16213687.
Conjunctival Melanoma: A Clinical Review and Update.
Butt K, Hussain R, Coupland S, Krishna Y Cancers (Basel). 2024; 16(18).
PMID: 39335093 PMC: 11429624. DOI: 10.3390/cancers16183121.
Conjunctival melanoma with pronounced central corneal invasion: One-year relapse free follow-up.
Englisch C, Berger T, Flockerzi F, Bofferding M, Seitz B Am J Ophthalmol Case Rep. 2024; 36:102162.
PMID: 39286547 PMC: 11403272. DOI: 10.1016/j.ajoc.2024.102162.
Grajewski L, Kneifel C, Wosle M, Ciernik I, Krause L Ocul Oncol Pathol. 2024; 10(3):162-167.
PMID: 39224526 PMC: 11368392. DOI: 10.1159/000539684.